Navigation Links
New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes

observational studies investigating the effects of Micardis (telmisartan) compared with other treatments, including other available ARBs, for hypertension. Note that these trials were investigational and were conducted to expand scientific knowledge of Micardis (telmisartan). These trials include treatment for conditions outside of the approved indications for Micardis (telmisartan).

*A prospective, randomised, double-blind, double-dummy, forced-titration, multicenter, parallel group, 1-year treatment trial to compare telMisartan 40 mg titrated to 80 mg versus losArtan 50 mg titrated to 100 mg, in hypertensive type 2 DiabEtic patients with Overt nephropathy.

About Micardis(R) (telmisartan) tablets

MICARDIS is an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension and may be used alone or in combination with other antihypertensive agents. In the clinical trial programs PROTECTION, ONTARGET and PRoFESS, over 58,000 patients have been enrolled to investigate the cardiovascular protective effects of MICARDIS.

For more information and full prescribing information, please visit www.MICARDIS.com


    Safety Information


USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, MICARDIS Tablets should be discontinued as soon as possible (see WARNINGS, Fetal/Neonatal Morbidity and Mortality).

MICARDIS is indicated for the treatment of hypertension.

MICARDIS is contraindicated in patients who are hypersensitive to any of its components.

In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of MICARDIS therapy.
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
Post Your Comments:
(Date:9/2/2014)... , Spanien, September 2, 2014 ... Das auf dem ESC-Kongress 2014 präsentierte ... Behandlung und Behandlungsergebnisse von schlaganfallgefährdeten Patienten ... Die Daten der ... Patienten, einer innovativen und unabhängigen Forschungsinitiative ...
(Date:9/2/2014)... Sept. 2, 2014 Particle Sciences, the leading ... investment in development and manufacturing capabilities with the addition ... Mueller , Particle Sciences, Associate Director Clinical Production, "The ... clean room square footage, equipment and staff across the ... company now has over 6000ft 2 of operating ...
(Date:9/2/2014)... , Sept. 2, 2014  Edison Nation Medical, ... partnership with the American Association for Respiratory Care ... respiratory care specialists. Edison Nation Medical, which brings ... business to commercialize their innovation ideas, will work ... of more than 50,000 respiratory therapists in bringing ...
Breaking Medicine Technology:Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 3
... Systems, Inc., today announced its nGage™ system has ... monitoring system in the United States.  The nGage ... cleansings. Hospitals have experienced an average ... implementation of the Proventix monitoring system. This improvement ...
... Pa., Nov. 29, 2011 Winter brings a whole set ... even worse for the 7.5 million Americans who suffer from ... from sunlight and other environmental factors rob the skin of ... Additionally, winter colds weaken the immune system, making it harder ...
Cached Medicine Technology:Proventix's nGage™ the Most Widely Used Automated Healthcare Hand Hygiene Monitoring System in the United States 2Proventix's nGage™ the Most Widely Used Automated Healthcare Hand Hygiene Monitoring System in the United States 3PhotoMedex Helps Psoriasis Patients Ease Winter Skin Care Woes 2PhotoMedex Helps Psoriasis Patients Ease Winter Skin Care Woes 3PhotoMedex Helps Psoriasis Patients Ease Winter Skin Care Woes 4
(Date:9/2/2014)... believe that marijuana is not addictive, but a new ... able to obtain and consume cannabis legally for medical ... likely to perceive it as addictive or harmful," study ... Center for Addiction Medicine, said in a hospital news ... have significant consequences, and we know that among adolescents ...
(Date:9/2/2014)... PA (PRWEB) September 02, 2014 ... communications and education, is proud to announce the acquisition ... clinical resource center designed for healthcare professionals who integrate ... offers practitioners comprehensive access to:, , ... Dedicated topic centers for diabetes, oncology, renal ...
(Date:9/2/2014)... Mass. (PRWEB) September 02, 2014 Healthcare ... latest and most complete oncology guidelines available at the ... Health and the National Comprehensive Cancer Network® ... with other evidence and guidelines in the content available ... , NCCN, a not-for-profit alliance of 25 of ...
(Date:9/2/2014)... from cancer surgery may be influenced by more ... Family conflicts and other non-medical problems may raise ... study has found. Addressing such quality-of-life issues before ... recoveries and save health care dollars, the research ... patients, and found that patients with a poor ...
(Date:9/2/2014)... New research involving mice suggests that the key to ... medicine cabinet. In a report published in the ... that macrophages from the lungs of old mice had ... from young mice, but these changes were reversed by ... consequences on immune function," said Joanne Turner, Ph.D., a ...
Breaking Medicine News(10 mins):Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 3Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 4Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2
... calls for specialized pediatric care, researchers say , ... to account for about 44 percent of the estimated ... earthquake -- information that could be used to guide ... the team at Children,s Hospital Los Angeles and the ...
... report using treatments, study finds, , THURSDAY, Jan. 28 ... adolescents in the United States use complementary or alternative ... researchers. , Most of these children have serious chronic ... effectiveness of the alternative remedies, especially when they are ...
... , PALM CITY, Fla. , ... Sheets: CTYX) is pleased to announce that it has secured ... U.S. Trademark #3,739,453 for the protection of the MedFlash name, ... Cl.: 9 designation in class 9 (U.S. CLS. 21, 23, ...
... Consumer survey results indicate ,having work done, not taboo ... Cosmetic surgery is everywhere these days: TV, magazines, the ... indeed more comfortable talking about cosmetic surgery than ever before. ... of Cosmetic Surgery, 71 percent of respondents think society is ...
... , , , , , ... Jan. 28 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. (OTC Bulletin ... and supplier of pharmaceutical,products and medical nutrients addressing a ... January 22, 2010 , its Board of Directors had,appointed ...
... ... today that it has been selected by Central Garden & Pet Company (NASDAQ:CENT) as ... ... -- SiteHawk, the leading MSDS and chemical data management company, announced today that it ...
Cached Medicine News:Health News:Haitian Children Need Specific Relief Efforts 2Health News:Kids' Use of Alternative Therapies Often Mimics Parents' 2Health News:Connectyx Granted U.S. Trademark for MedFlash(R) 2Health News:Connectyx Granted U.S. Trademark for MedFlash(R) 3Health News:Society More Open Than Ever About Cosmetic Surgery 2Health News:Biostar Pharmaceuticals, Inc. Announces Change of Auditor 2Health News:Biostar Pharmaceuticals, Inc. Announces Change of Auditor 3Health News:Central Garden & Pet Selects SiteHawk as Its MSDS Management Provider 2
... Insertion Through A 1.0mm Incision., ,Special Direct ... ... Comfortable Approach., ,Recessed Jaws For Improved Sub-Incisional ... Of Jaws During Sterilization., ,Reusable, Autoclaveable, Guaranteed ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
... Corneal Gauges Allowing The Exact,Outer Diameter Measurement ... With 0.25mm ,Increments.,Easy And Quick To Use, ... And Place Over A Cornea For Confirmation ... The USA, ...
... Gauge Measures 360 Degrees & Can Be Set ... Cornea. 7mm Inner Diameter & 14mm Outer Diameter ... Astigmatism Gauge That Can Be Set For AKs, ... Around The Globe., ,Marks Single Or Paired AKs, ...
Medicine Products: